Sunday, June 22, 2025

Tag: Q3FY25

Browse our exclusive articles!

Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25

New admin admin -
Biocon's board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is...
12Page 2 of 2

Popular

Retail investors to ride the algo wave with Sebi’s new trading framework

Latest 0

Iran seeks urgent IAEA meeting after US strike on nuclear site

Global 0
Director General of the International Atomic Energy Agency, Rafael...

Ahead of US strike on Iran, fund flows into EMs hit a 28-month high

Global 0
The past two spikes in global fund flows were...

India assures Sri Lanka, Nepal of evacuating their nationals from Iran

Global 0
India on Saturday (June 21) assured Sri Lanka and...

Subscribe

spot_imgspot_img
© 2025 JMD Associates. All Rights Reserved. Partnered with Master Trust for Comprehensive Investment Solutions.